Tectonic Therapeutic (TECX) Other Non Operating Income (2020 - 2026)
Tectonic Therapeutic (TECX) reported Other Non Operating Income of -$113000.0 for Q1 2026, down 253.12% year-over-year from $73795.9 in Q1 2025, and down 1312.5% quarter-over-quarter from -$8000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Other Non Operating Income (2020 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 7 years of Other Non Operating Income data on file, last reported at -$113000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$113000.0, down 253.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$200000.0 (down 43.88% YoY), and the FY2025 annual result was -$119000.0, up 76.71% from the prior year.
- Other Non Operating Income fell to -$113000.0 in Q1 2026 per TECX's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $406000.0 in Q4 2023 and troughed at -$403000.0 in Q1 2024.
- A 5-year average of -$29062.5 and a median of -$19500.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income surged 133.33% in 2023, then tumbled 2786.67% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at -$95000.0 in 2022, then soared by 527.37% to $406000.0 in 2023, then sank by 123.4% to -$95000.0 in 2024, then jumped by 91.58% to -$8000.0 in 2025, then slumped by 1312.5% to -$113000.0 in 2026.
- Business Quant data shows TECX's Other Non Operating Income at -$113000.0 in Q1 2026, -$8000.0 in Q4 2025, and -$31000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | -95,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -8,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Sep 30, 2022 | -95,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -45,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Sep 30, 2020 | -74,000.00 |